A group of nanotechnology researchers in Iran is up to nine retractions after losing four papers in a go for problematic figures. The work was led by Abolfazl Akbarzadeh, a medicinal chemist at Tabriz University of Medical Sciences, who has spent time as a visiting professor at Boston University and UCLA. Commenters on PubPeer including … Continue reading Nanotech group up to nine retractions
A group of nutrition researchers in Canada led by the prominent diabetes scientist Emile Levy has lost three papers in PLOS ONE over concerns about the integrity of the data. The concerns were raised nearly eight years ago by Elisabeth Bik, early in her career as a data sleuth. In May 2014, Bik told us, … Continue reading 8 years after three papers are flagged — and after losing original correspondence — PLOS ONE retracts
Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Cancer researcher faked data for 24 images in work funded by nine NIH grants: Federal watchdog The author of a retracted paper learns to be careful what he wishes for Journals acknowledge that a … Continue reading Weekend reads: Should open access advocates vilify publishers?; authorship for sale, $5,000; is economics just ‘bafflegab?’
A researcher at the center of questions about a biotech’s controversial experimental treatment for Alzheimer’s disease has lost five papers in PLOS One. The journal says it is retracting the articles, by Hoau-Yan Wang and colleagues, over concerns about the integrity of the data and the images in the papers. Wang does not agree with … Continue reading Five studies linked to Cassava Sciences retracted
Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: The 21-year-old apology – and retraction from JAMA Harvard eye researchers have eight papers retracted for lack of ethical approval Einstein duo faked data in 16 federal grant applications: ORI So what happened with … Continue reading Weekend reads: Concussion researcher faces more scrutiny; ‘Mendel the fraud?’; seeking redemption after misconduct finding
Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Authors request retraction of study in Nature journal and look into four more papers Study on teen pot use goes up in smoke, then reappears UNC-Chapel Hill vice chancellor resigns post after admitting to … Continue reading Weekend reads: Journals’ Russia bans; a chronic fatigue syndrome retraction; a Twitter retraction notice feature?
The Journal of Neuroscience has slapped expressions of concern on a pair of papers linked to the maker of a controversial drug to treat Alzheimer’s disease. As we and others have reported, Cassava Sciences has been under intense scrutiny lately. In August, the law firm Labaton Sucharow – who is representing Cassava short sellers – … Continue reading Two expressions of concern arrive for papers linked to beleaguered biotech Cassava
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Our co-founder Ivan Oransky presented oral evidence to the UK … Continue reading Weekend reads: Chair leaves post during investigation of double-dipping allegations; geoscientist fined; prof claims another’s papers are hers
A journal is considering issuing an expression of concern for a 2005 paper by authors tied to a company that’s now under investigation for fraud, Retraction Watch has learned. [See an update on this post (bottom).] The article, “Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gβγ … Continue reading Journal mulls expression of concern for Cassava Sciences paper
The publisher IOS Press retracted a total of 79 papers last month from two journals, some for citing work unrelated to the subject of the articles and some for, well, everything. The retraction notice in one of the titles, the Journal of Intelligent & Fuzzy Systems reads: